LYVE1 and Alzheimer disease: The data demonstrate that Ab‐TP‐MDNPs treatment significantly improved lymphatic structure as evidenced by increased morphological uniformity and lymph vessel density of LYVE‐1+ lymphatic vessels in the AD brain by 100% in the inner meningeal layer and by 86% in the straight sinus as compared to vehicle treatment.